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Pediatric acute kidney injury: The 
use of the RIFLE criteria
DJ Askenazi1 and TE Bunchman2
Outcome in pediatric acute kidney injury (AKI) is in part related to 
diagnosis and intervention. Standard markers of severity of illness 
do not identify AKI. Modified RIFLE criteria are shown to identify 
patients who develop AKI, potentially allowing for early intervention.
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Based on urine output volume and 
changes in glomerular filtration rate, 
the RIFLE criteria (risk, injury, failure, 
loss, and end-stage renal disease) to 
classify acute kidney injury (AKI) were 
proposed by the Acute Dialysis Quality 
Initiative Group in 2001 and have been 
adopted by most intensive care units and 
nephrology societies as a way to defi ne 
AKI.1 The RIFLE criteria have been 
shown to independently predict length 
of stay, costs, morbidity, and mortality 
in adults, and RIFLE predicts renal mor-
bidity and mortality better than acute 
physiological assessment and chronic 
health evaluation (APACHE) in the 
adult population.
Pediatric studies to date are limited, 
as they were performed in single centers 
and the patients selected had high mor-
bidities and mortalities and AKI that was 
severe enough to require renal replace-
ment therapy.2–4 Some multicenter 
studies using retrospective databases 
have shown improvement of survival in 
patients with AKI on renal replacement 
therapy, yet no adequate predictors of 
AKI outcomes have been found.5 Simi-
lar to the APACHE score in adults, the 
pediatric risk of mortality (PRISM) score 
in pediatrics does not adequately predict 
renal and hospital survival.6 Th e article 
by Akcan-Arikan et al.7 (this issue) is the 
fi rst of its kind, as it explores a modifi ed 
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pediatric RIFLE in children with multi-
organ dysfunction.
Th is work by the Texas Children’s Hos-
pital group at Baylor College of Medicine 
looks at a prospective series of children 
admitted to their intensive care unit over a 
year’s period. Th ey found that AKI is very 
common, as 113 of 150 pediatric patients 
requiring ventilation (82%) developed 
AKI.7 In addition, this group has shown 
for the fi rst time that AKI as judged by 
a modified pediatric RIFLE predicts 
increased cost, length of stay, mortality, 
and need for renal replacement therapy. 
Th ey validate its use in those pediatric 
patients with neuromuscular disease and 
show that RIFLE is as good as or better 
than PRISM scores at predicting outcomes 
in pediatric patients with AKI.
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Figure 1 | Strategies to improve outcome in children with acute kidney injury (AKI): where 
we are, and where we are going. NGAL; neutrophil gelatinase-associated lipocalin. KIM-1; kidney 
injury molecule 1.
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Further, these authors hope this new 
model will now be implemented at other 
programs in pediatric intensive care and 
nephrology units to help look at early 
markers and measurement of AKI (Fig-
ure 1).8 Th is work in combination with 
urinary markers such as neutrophil gela-
tinase-associated lipocalin (NGAL) and 
interleukin-18 may be used to predict who 
is at risk for developing short-term and 
long-term renal damage9,10 and to iden-
tify early interventions that may improve 
morbidity, mortality, and length of stay by 
improving the quality of care of children.
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